Guangdong Biolight Meditech Co Ltd Total Assets
Guangdong Biolight Meditech Co Ltd total assets. Based on the latest financial reports, Guangdong Biolight Meditech Co Ltd (300246) holds total assets worth CN¥2.45 Billion CNY (≈ $359.07 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Guangdong Biolight Meditech Co Ltd (300246) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Guangdong Biolight Meditech Co Ltd (2008–2025)
Total assets of Guangdong Biolight Meditech Co Ltd from 2008 to 2025. This chart illustrates how Guangdong Biolight Meditech Co Ltd's total assets have evolved over time, based on quarterly financial data. See Guangdong Biolight Meditech Co Ltd (300246) stock price for real-time trading data and today's change.
Guangdong Biolight Meditech Co Ltd - Asset Composition Analysis
Guangdong Biolight Meditech Co Ltd Total Assets Breakdown (December 2025)
Guangdong Biolight Meditech Co Ltd total assets breakdown as of December 2025. Guangdong Biolight Meditech Co Ltd's total assets of CN¥2.45 Billion consist of 50.6% current assets and 49.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 26.8% |
| Accounts Receivable | CN¥242.14 Million | 9.6% |
| Inventory | CN¥287.82 Million | 11.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥116.51 Million | 4.6% |
| Goodwill | CN¥15.49 Million | 0.6% |
Asset Composition Trend (2008–2025)
This chart illustrates how Guangdong Biolight Meditech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Guangdong Biolight Meditech Co Ltd (300246) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangdong Biolight Meditech Co Ltd's current assets represent 50.6% of total assets in 2025, a decrease from 78.9% in 2008.
- Cash Position: Cash and equivalents constituted 26.8% of total assets in 2025, up from 18.3% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 1.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 11.4% of total assets.
Guangdong Biolight Meditech Co Ltd Competitors by Total Assets
Key competitors of Guangdong Biolight Meditech Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Guangdong Biolight Meditech Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.44 | 2.19 | 1.84 |
| Quick Ratio | 1.09 | 1.72 | 1.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥376.42 Million | CN¥642.30 Million | CN¥385.96 Million |
Guangdong Biolight Meditech Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guangdong Biolight Meditech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.52 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | CN¥2.52 Billion |
| Market Capitalization | $483.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values Guangdong Biolight Meditech Co Ltd's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Guangdong Biolight Meditech Co Ltd's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Guangdong Biolight Meditech Co Ltd (2008–2025)
The table below shows the annual total assets of Guangdong Biolight Meditech Co Ltd from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.52 Billion ≈ $369.09 Million |
+0.94% |
| 2024-12-31 | CN¥2.50 Billion ≈ $365.66 Million |
-1.40% |
| 2023-12-31 | CN¥2.53 Billion ≈ $370.86 Million |
+3.92% |
| 2022-12-31 | CN¥2.44 Billion ≈ $356.88 Million |
+41.83% |
| 2021-12-31 | CN¥1.72 Billion ≈ $251.62 Million |
+6.99% |
| 2020-12-31 | CN¥1.61 Billion ≈ $235.18 Million |
+67.16% |
| 2019-12-31 | CN¥961.46 Million ≈ $140.69 Million |
+4.72% |
| 2018-12-31 | CN¥918.15 Million ≈ $134.35 Million |
+14.74% |
| 2017-12-31 | CN¥800.22 Million ≈ $117.10 Million |
+16.55% |
| 2016-12-31 | CN¥686.57 Million ≈ $100.47 Million |
+18.24% |
| 2015-12-31 | CN¥580.65 Million ≈ $84.97 Million |
+11.88% |
| 2014-12-31 | CN¥519.01 Million ≈ $75.95 Million |
+10.03% |
| 2013-12-31 | CN¥471.72 Million ≈ $69.03 Million |
+8.82% |
| 2012-12-31 | CN¥433.50 Million ≈ $63.43 Million |
+9.34% |
| 2011-12-31 | CN¥396.48 Million ≈ $58.02 Million |
+209.73% |
| 2010-12-31 | CN¥128.01 Million ≈ $18.73 Million |
+23.82% |
| 2009-12-31 | CN¥103.38 Million ≈ $15.13 Million |
+31.86% |
| 2008-12-31 | CN¥78.41 Million ≈ $11.47 Million |
-- |
About Guangdong Biolight Meditech Co Ltd
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, el… Read more